254 related articles for article (PubMed ID: 19582775)
1. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
[TBL] [Abstract][Full Text] [Related]
2. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells.
Tobimatsu T; Kaji H; Sowa H; Naito J; Canaff L; Hendy GN; Sugimoto T; Chihara K
Endocrinology; 2006 May; 147(5):2583-90. PubMed ID: 16484320
[TBL] [Abstract][Full Text] [Related]
4. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
5. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
7. Smad3 differently affects osteoblast differentiation depending upon its differentiation stage.
Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2006 Nov; 38(11):740-5. PubMed ID: 17111301
[TBL] [Abstract][Full Text] [Related]
8. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
McCauley LK; Koh AJ; Beecher CA; Cui Y; Decker JD; Franceschi RT
J Bone Miner Res; 1995 Aug; 10(8):1243-55. PubMed ID: 8585429
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
Kwok S; Qin L; Partridge NC; Selvamurugan N
J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
[TBL] [Abstract][Full Text] [Related]
10. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.
Hendy GN; Kaji H; Sowa H; Lebrun JJ; Canaff L
Horm Metab Res; 2005 Jun; 37(6):375-9. PubMed ID: 16001330
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway.
Hisa I; Inoue Y; Hendy GN; Canaff L; Kitazawa R; Kitazawa S; Komori T; Sugimoto T; Seino S; Kaji H
J Biol Chem; 2011 Mar; 286(11):9787-96. PubMed ID: 21239498
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts.
Sowa H; Kaji H; Iu MF; Tsukamoto T; Sugimoto T; Chihara K
J Biol Chem; 2003 Dec; 278(52):52240-52. PubMed ID: 14517210
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
Sato M
Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
[TBL] [Abstract][Full Text] [Related]
15. Effects of secreted frizzled-related protein 3 on osteoblasts in vitro.
Chung YS; Baylink DJ; Srivastava AK; Amaar Y; Tapia B; Kasukawa Y; Mohan S
J Bone Miner Res; 2004 Sep; 19(9):1395-402. PubMed ID: 15312239
[TBL] [Abstract][Full Text] [Related]
16. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling.
Sumi T; Tsuneyoshi N; Nakatsuji N; Suemori H
Development; 2008 Sep; 135(17):2969-79. PubMed ID: 18667462
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of bone anabolic action by PTH].
Kaji H
Clin Calcium; 2012 Mar; 22(3):321-6. PubMed ID: 22370298
[TBL] [Abstract][Full Text] [Related]
18. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells.
van der Horst G; van der Werf SM; Farih-Sips H; van Bezooijen RL; Löwik CW; Karperien M
J Bone Miner Res; 2005 Oct; 20(10):1867-77. PubMed ID: 16160745
[TBL] [Abstract][Full Text] [Related]
20. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts.
Chan TF; Couchourel D; Abed E; Delalandre A; Duval N; Lajeunesse D
J Bone Miner Res; 2011 Jul; 26(7):1399-410. PubMed ID: 21312269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
